新世界发展(00017.HK)推1,000元接种疫苗资助 首阶段名额5,000个
新世界发展(00017.HK)公布,将推出新一轮抗疫措施协助基层市民,受惠者可获1,000元资助,作为疫苗接种薪金或健康谘询的津贴。首阶段名额约5,000个,由三间非牟利机构推荐及甄选服务对象,并安排发放方式,最快於本月底开始发放津贴。
新世界将推出首轮关顾基层人士接种疫苗的津贴计划,并夥拍香港路德会社会服务处、香港社区组织协会及圣雅各福群会,合共向5,000位基层人士发放津贴,受惠者可获1,000元资助,作为疫苗接种薪金或健康谘询的津贴,由三间非牟利机构推荐及甄选服务对象,并安排发放方式,包括视乎受惠者的工作机构有否提供有薪针假、其健康谘询或身体检查需要,以及行业相关的需要等,务求令有需要的基层市民获得适切协助,在无後顾之忧的情况下接种疫苗。
疫苗接种的津贴预计由6月底至8月底陆续分批发放,受惠者须向有关非牟利机构出示已接种两剂疫苗的纪录,发放详情稍後由三间非牟利团体各自公布。集团并已预留额外500万元,视乎疫情发展,有需要时将研究展开第二阶段计划。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.